84-2465-19　PRKRA (Interferon-inducible Double Stranded RNA-dependent Protein Kinase Activator A, PKR-associated Protein X, PACT, RAX, PKR-associating Protein X, Protein Activator of the Interferon-induced Protein Kinase, Protein Kinase, Interferon-inducible Double Stranded RNA-dependent Activator, HSD-14, HSD14, DYT16) APC 100ul　131820-APC

特徴

• PRKRA appears to have a pro-apoptotic function that may be suppressed in the presence of growth factor.
• It activates EIF2AK2 in the absence of double-stranded RNA (dsRNA).
• Applications:Suitable for use in Western Blot.
• Other applications not tested.
• Recommended Dilution:Optimal dilutions to be determined by the researcher.
• AA Sequence:MSQSRHRAEAPPLEREDSGTFSLGKMITAKPGKTPIQVLHEYGMKTKNIPVYECERSDVQIHVPTFTFRVTVGDITCTGEGTSKKLAKHRAAEAAINILKANASICFAVPDPLMPDPSKQPKNQLNPIGSLQELAIHHGWRLPEYTLSQEGGPAHKREYTTICRLESFMETGKGASKKQAKRNAAEKFLAKFSNISPENHISLTNVVGHSLGCTWHSLRNSPGEKINLLKRSLLSIPNTDYIQLLSEIAKEQGFNITYLDIDELSANGQYQCLAELSTSPITVCHGSGISCGNAQSDAAHNALQYLKIIAERK
• Storage and Stability:Store product at 4°C in the dark.
• DO NOT FREEZE! Stable at 4°C for 12 months after receipt as an undiluted liquid.
• Dilute required amount only prior to immediate use.
• Further dilutions can be made in assay buffer.
• Caution: APC conjugates are sensitive to light.
• For maximum recovery of product, centrifuge the original vial prior to removing the cap.
• Note: Applications are based on unconjugated antibody.